Autotransfusion Systems Market report reviews trends, industry size, share, growth, analysis and forecast 2025 – WhaTech Technology and Markets News

Global Autotransfusion Systems Market Size, Share & Trends Analysis Report, By Application (Orthopedic Surgery, Cardiac Surgery, Trauma Procedures, Organ Transplantation, and Other Procedures), By Type (Autotransfusion Products and Accessories) Forecast, 2019-2025

The global auto transfusion systems market is estimated to grow at a CAGR of 5.6% during the forecast period. The major factors contributing to the market growth include the rising number of surgeries, increasing demand for organ transplantation, and emerging focus on patient blood management.

The rising number of organ transplantation procedures have witnessed over the years. For instance, as per the Global Observatory on Donation and Transplantation (GODT), in 2017, the number of organs transplanted was 139,024, which increased to 7.3% over 2015.

There were 16 transplants per hour in 2017. Of these, 90,306 kidney transplants and 32,348 liver transplants were performed in 2017.

This rising demand for organ transplants is leading to increasing demand for autologous blood transfusion for patients blood management during the organ transplantation procedure.

Get Sample Copy of Autotransfusion Systems Market at: http://www.omrglobal.com/requestems-market

Major Key Players - Advancis Surgical, Atrium Medical Corp.,B. Braun Melsungen AG,Becton, Dickinson and Co.,Beijing ZKSK Technology Co., Ltd.

BraileBiomdica,Brightwake Ltd.,Ecomed Solutions, LLC,Fresenius KabiAG,Gen World Medical Devices,Getinge AB,Haemonetics Corp.,LivaNova PLC,Medtronic plc

Autologous blood transfusion has been increasingly gaining significance owing to the growing concerns of blood shortage and blood transfusion safety. With the advances in blood conservation methods, blood transfusion medicine, blood component separation technology, and continuous growth in clinical needs, the scope of ABT technology has been broadened and innovated to a significant extent.

There is a significant need for management of blood loss in organ transplantation procedure. As a result, autologous transfusion is utilized as a strategy to minimize the incidence of the harmful effects of allogeneic transfusion.

The method is employed to avoid the extreme use of donated blood.

A full report of Global Autotransfusion Systems Market is available at: http://www.omrglobal.com/industrems-market

Market Segmentation

Global Autotransfusion Systems Market by Application

Global Autotransfusion Systems Market by Type

Preoperative autologous transfusion involves collecting patients blood and stored for a period of time. As there is no determined date for liver transplants, excluding cases which involve living donors, blood collection in advance is normally not feasible.

Therefore, intraoperative blood salvage auto transfusion (IBSA) is employed as a strategy for autologous transfusion. IBSA involves the recovery of blood loss during the procedure and returns it to the patients body by infusion.

This eliminates the need for an allogeneic blood transfusion which may have an impact on recipient survival and an immunosuppressive effect. Allogeneic transfusion increases the risk of transmission of viral infections and transfusion errors among patients.

This, in turn, is contributing to the demand for auto transfusion systems in organ transplant procedures to manage blood loss and increasing safety and effectiveness during the procedure.

For more customized data, request for report customization @ http://www.omrglobal.com/report-ems-market

This email address is being protected from spambots. You need JavaScript enabled to view it.

Link:
Autotransfusion Systems Market report reviews trends, industry size, share, growth, analysis and forecast 2025 - WhaTech Technology and Markets News